Published in Cancer Weekly, June 20th, 2000
"Various conventional chemotherapeutic drugs can block angiogenesis or even kill activated, dividing endothelial cells," stated G. Klement and colleagues, Sunnybrook & Women's College, Canada. "Such effects may contribute to the antitumor efficacy of chemotherapy in vivo and may delay or prevent the acquisition of drug-resistance by cancer cells. We have implemented a treatment regimen that augments the potential antivascular effects of chemotherapy, that is devoid of obvious...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.